Your browser doesn't support javascript.
loading
[Efficacy and safety of neoadjuvant apatinib in combination with dose-dense paclitaxel and carboplatin in locally advanced triple negative breast cancer patients].
Ou, K P; Li, Q; Luo, Y; Lyu, J J; Zhou, H; Yang, Y; Cai, Y J; Wang, Z J; Wang, X; Qi, L Q; Ma, F; Xu, B H.
Afiliación
  • Ou KP; Department of Medicine, Beijing Chaoyang Sanhuan Cancer Hospital, Beijing 100122, China.
  • Li Q; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Luo Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Lyu JJ; Department of Medicine, Beijing Chaoyang Sanhuan Cancer Hospital, Beijing 100122, China.
  • Zhou H; Department of Medicine, Beijing Chaoyang Sanhuan Cancer Hospital, Beijing 100122, China.
  • Yang Y; Department of Medicine, Beijing Chaoyang Sanhuan Cancer Hospital, Beijing 100122, China.
  • Cai YJ; Department of Medicine, Beijing Chaoyang Sanhuan Cancer Hospital, Beijing 100122, China.
  • Wang ZJ; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Wang X; Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Qi LQ; Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Ma F; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Xu BH; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Zhonghua Zhong Liu Za Zhi ; 42(11): 966-971, 2020 Nov 23.
Article en Zh | MEDLINE | ID: mdl-33256310
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piridinas / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia Neoadyuvante / Neoplasias de la Mama Triple Negativas Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Female / Humans Idioma: Zh Revista: Zhonghua Zhong Liu Za Zhi Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piridinas / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia Neoadyuvante / Neoplasias de la Mama Triple Negativas Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Female / Humans Idioma: Zh Revista: Zhonghua Zhong Liu Za Zhi Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: China